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Abstract Hyperglycemia induces insulin resistance in diabetic
patients. It is known that supraphysiological levels of D-glucose
or 2-deoxyglucose inhibit the insulin receptor and it is speculated
that this effect is mediated by serine phosphorylation of the
insulin receptor L-subunit and other proteins of the insulin
signaling chain. To test this hypothesis we prepared point
mutations of the human insulin receptor where serine was
exchanged to alanine at 16 different positions, either at known
phosphorylation sites or at positions which are conserved in
different tyrosine kinase receptors. These receptor constructs
were expressed in HEK 293 cells and the effect of 2-deoxyglu-
cose (25 mM) on insulin (100 nM) induced receptor autophos-
phorylation was studied. 2-Deoxyglucose consistently inhibits
insulin stimulated autophosphorylation of all constructs to the
same degree as observed in wild-type human insulin receptor. The
data suggest that none of the chosen serine positions are involved
in 2-deoxyglucose induced receptor inhibition.
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1. Introduction
Hyperglycemia contributes to the pathogenesis of insulin
resistance both in NIDDM and IDDM patients [1,2]. The
underlying mechanism appears to involve both a modulation
of insulin signaling at the level of the insulin receptor as well
as a modulation of signaling events downstream of the recep-
tor [3^5]. E¡ects of high glucose concentrations on the tyro-
sine kinase activity of the insulin receptor have been demon-
strated in a number of di¡erent cell types including freshly
isolated rat adipocytes as well as rat-1 ¢broblasts overexpress-
ing HIR [1,3,6]. We have earlier used these cultured cell lines
to characterize the mechanism which is relevant for hypergly-
cemia induced receptor inhibition [7,8] and found evidence
that a glucose induced activation of protein kinase C is in-
volved. Other investigators have suggested that activation of
tyrosine phosphatases may be important in hyperglycemia in-
duced receptor inhibition [9]. According to studies in HEK
293 cells the PKC isoforms K, L1, L2 and a are able to inhibit
the insulin receptor [10] but the exact mechanism remains
unclear. A phosphorylation of the receptor L-subunit [11,12]
and the insulin receptor substrate-1 [10] at serine residues
might be involved in this e¡ect.
The aim of the present study was to obtain direct evidence
for a role of speci¢c serine residues in the receptor for glucose
induced receptor inhibition. Attempts to ¢nd 2-deoxyglucose
stimulated serine phosphorylation sites in the receptor using
32P-labeled cells were so far unsuccessful. As an alternative
approach to de¢ne relevant serine residues we have used in-
sulin receptor constructs with either a 43 amino acid deletion
at the C-terminal tail of the L-subunit or a 12 amino acid
deletion at the juxtamembrane region of the insulin receptor
to de¢ne the role of potential serine phosphorylation sites in
these regions for glucose and 2-deoxyglucose dependent recep-
tor inhibition [8]. These deletions, which eliminate the candi-
date sites at positions 955/956 and 962/964 [13] as well as the
candidate sites 1308/09 and 1315, were e⁄ciently inhibited by
hyperglycemic incubation conditions excluding a function of
these serine residues in hyperglycemia dependent receptor in-
hibition. Now we prepared point mutations of the human
insulin receptor in which serine was exchanged to alanine at
16 di¡erent positions and transiently expressed these con-
structs in HEK 293 cells. The candidate sites were chosen
either because they are known serine phosphorylation sites
including 1023/25 [14], 1293/94, [15,16] and 1309 (with the
neighboring serine 1308) [17] or because they are conserved
in di¡erent receptor tyrosine kinases (HIR, hIGF-1 receptor,
hIRR and dIR). As outlined by Danielsen et al. [18], these
positions include 962, 994, 1037, 1055, 1074/78, 1177/78/82,
1202, 1263 and 1267. Among these Ser-1178 and Ser-1182
are also conserved in other receptor tyrosine kinases, i.e. the
EGF-R, PDGF-R and FGF receptors [19]. In addition we
used other closely related serine mutants (HIR-1192, HIR-
1258, HIR-1275) and the juxtamembrane deleted receptor
(HIR-vJM). HEK 293 cells transiently overexpressing the re-
spective constructs were exposed to 25 mM 2-deoxyglucose
and the e¡ect on insulin stimulated HIR autophosphorylation
was determined.
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2. Materials and methods
2.1. Materials
Cell culture reagents and fetal calf serum were purchased from
Gibco (Eggenstein, Germany); culture dishes were from Greiner
(Frickenhausen, Germany). Porcine insulin, aprotinin, phenylmethyl-
sulfonyl £uoride, Na3VO4 and Triton X-100 were from Sigma (Mu-
nich, Germany). The reagents for SDS-PAGE and Western blotting
were obtained from Roth (Karlsruhe, Germany) and Bio-Rad (Mu-
nich, Germany). Nitrocellulose was from Schleicher and Schuell (Das-
sel, Germany). All other reagents were of the best grade commercially
available. Visualization of immunocomplexes after Western blotting
was performed with the non-radioactive enhanced chemiluminescence
system (ECL) and the Hyper¢lm-ECL from Amersham Buchler
(Braunschweig, Germany).
The cDNAs for the wild-type receptor (HIR-wt) and the insulin
receptor with a juxtamembrane deletion (HIR-vJM) were gifts from
Axel Ullrich (Max-Planck-Institute, Martinsried, Germany). The
monoclonal mouse antibody against phosphorylated tyrosine residues
(KPY) were from Leinco Technology Inc. (Ballwin, USA).
2.2. Preparation of serine to alanine point mutants of HIR
All point mutations were prepared by the method of Kunkel [20] in
a CMV promoter based expression vector [21] containing the cDNA
sequence for the wild-type human insulin receptor. The mutagenic
oligos were purchased from Boehringer Mannheim (Mannheim, Ger-
many). Introduced point mutations were veri¢ed by DNA sequencing
using the Sequenase version 2.0 kit (United States Biochemical, Cleve-
land, OH, USA).
2.3. Transient expression of HIR mutants
Human embryonic kidney ¢broblast 293 cells (ATCC CRL 1573)
were grown in Dulbecco’s MEM/nutrient mix F12 medium supple-
mented with 10% fetal calf serum. A total of 4 Wg plasmid DNA was
transfected per semicon£uent 35 mm diameter dish according to the
protocol of Chen and Okayama [22]. Brie£y, cells were grown in 6 well
dishes at a density of 105 cells per well in 2 ml of medium. A total of
4 Wg supercoiled plasmid DNA was mixed with 0.25 M CaCl2 in a
¢nal volume of 0.1 ml. To this was added equal amount of 2Utrans-
fection bu¡er (50 mM BES, pH 6.95, 280 mM NaCl, 1.5 mM
Na2HPO4) and after incubation for 10 min at room temperature
the mixture was given dropwise to the cells. After incubation for
16 h at 37‡C and 3% CO2 the cells were serum starved for 24 h in
DMEM (1000 mg/l glucose) containing 2 mM glutamine.
2.4. Stimulation and cell lysis
According to the experiments serum starved cells were preincubated
with or without 25 mM 2-deoxyglucose for 25 min before stimulation
with 100 nM insulin for 5 min at 37‡C and lysed in 0.2 ml ice-cold
lysis bu¡er (50 WM HEPES pH 7.2, 150 mM NaCl, 1.5 mM MgCl2,
1 mM EGTA, 10% (v/v) glycerol, 1% (v/v) Triton X-100, 100 mM
NaF, 10 mM sodium pyrophosphate, 100 WM sodium orthovanadate,
1 mM PMSF, 10 Wg/ml aprotinin). Cleared crude cell lysates (20 min/
12 000Ug) were analyzed on 7.5% SDS-PAGE (40 Wl per lane).
2.5. Western blotting
Separated proteins were transferred to nitrocellulose membranes by
semi-dry electroblotting (transfer bu¡er: 48 mM Tris-HCl pH 7.5;
0.004% SDS; 39 mM glycine; 20% methanol). After transfer, the
membranes were blocked with NET-G bu¡er (150 mM NaCl, 5 mM
EDTA, 50 mM Tris, 0.05% Triton X-100 and 0.25% gelatine, pH 7.4)
for 1 h. Subsequently ¢lters were incubated with the ¢rst antibody
(KPY, KHIR-L) overnight at 4‡C. The membranes were washed four
times with NET bu¡er before being incubated with horseradish per-
oxidase-conjugated anti-mouse IgG or anti-rabbit IgG for 1 h at room
temperature. Visualization of immunocomplexes was performed by
enhanced chemiluminescence (ECL).
3. Results
Fig. 1 shows representative autoradiograms of insulin re-
ceptor autophosphorylation in HEK 293 cells. Cells trans-
fected with HIR-wt and di¡erent receptor mutants were
stimulated with or without 100 nM insulin for 5 min in the
presence or absence of 25 mM 2-deoxyglucose (2-DG). 2-DG
was added to the cells 25 min prior to insulin. Receptor au-
tophosphorylation was determined in immunoblots with phos-
photyrosine antibodies (KPY), the expression level of insulin
receptors was controlled by immunoblots with antibodies
against the C-terminal end of the insulin receptor L-subunit
(KHIR-L). One can see that 2-DG induces a consistent and
reproducible receptor inhibition in HEK 293 cells. In contrast
to this observation the glucose induced receptor inhibition
found in rat adipocytes and rat-1 ¢broblasts overexpressing
HIR was not reproducibly found in HEK 293 cells. Preincu-
bation of the cells with 25 mM glucose instead of 2-DG
Fig. 1. Insulin induced receptor autophosphorylation and the e¡ect of 2-DG. Whole cell lysates were prepared from HEK 293 ¢broblast. Cells
overexpressing the wild-type receptor or the mutant receptors were incubated with 25 mM 2-DG for 25 min and subsequently stimulated with
100 nM insulin at 37‡C for 5 min. Proteins were separated by SDS-PAGE; Western blots were probed with antibodies against phosphotyrosine
residues (KPY) or insulin receptor (KHIR-L). Representative immunoblots are shown. These results were reproduced in ¢ve di¡erent experi-
ments.
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caused inconsistent e¡ects (data not shown). While in some
experiments glucose inhibits HIR-wt and the di¡erent mu-
tants, in other experiments an even stimulatory e¡ect is ob-
served. The cellular conditions which determine whether glu-
cose is stimulatory or inhibitory are at present not clear.
Basal, insulin stimulated and 2-DG inhibited autophos-
phorylation of the insulin receptor were quanti¢ed by scan-
ning densitometry, shown in Fig. 2. Receptor autophospho-
rylation as determined by immunoblotting with PY antibody
was normalized for equal amounts of receptors based on the
immunoblots with the receptor antibody. The basal and in-
sulin stimulated autophosphorylation was not signi¢cantly al-
tered by most of the point mutations. Exceptions were found
only with the mutations at 994, 1023/25 and 1178 as reported
earlier [23]. To quantify the inhibitory e¡ect of 2-DG we set
the insulin stimulated receptor autophosphorylation of each
construct at 100%. We observed a reduction in the receptor
autophosphorylation of all constructs not signi¢cantly di¡er-
ent from that observed in HIR-wt (n = 5, þ S.E.M.).
4. Discussion
Our earlier studies in rat-1 ¢broblasts overexpressing hu-
man insulin receptor had suggested that the hyperglycemia
induced inhibition of the insulin receptor kinase involves pro-
tein kinase-C activation. We had also speculated that this
e¡ect requires serine phosphorylation of the insulin receptor
L-subunit. The evidence for this hypothesis is based on the
observation that di¡erent protein kinase-C inhibitors were
able to prevent the e¡ect of hyperglycemia [6]. Furthermore,
a phosphoamino acid analysis of the receptor L-subunit has
shown a small increase of serine phosphorylation of the re-
ceptor L-subunits in cells incubated in the presence of high
glucose levels [7]. While we could further substantiate the in-
hibitory role of speci¢c PKC isoforms [10], the hypothesis of a
direct phosphorylation of the receptor L-subunit could not be
further proven. As a ¢rst approach to ¢nd serine sites in the
insulin receptor we had earlier eliminated a number of candi-
date sites using insulin receptor constructs with C-terminal
and juxtamembrane deletions which were stably overexpressed
in rat-1 ¢broblasts [8]. In the present paper we continued this
approach by preparing systematically a number of further
HIR mutants eliminating known phosphorylation sites of
the receptor L-subunit and all conserved serine residues which
were thought to be candidates. In HEK 293 cells a transient
overexpression of di¡erent constructs is possible, therefore
this cell system is suitable to screen rapidly the function of
these HIR constructs. Under our experimental conditions this
cell system reacts to glucose not in the same way as was the
case in adipocytes and rat-1 ¢broblasts [3,6]. In contrast, the
e¡ects of 2-deoxyglucose are the same as observed in rat-1
¢broblasts. The reason for this cell speci¢c di¡erence is at
present unclear. Unpublished data by Mosthaf et al. suggest
that the expression level of the insulin receptor might be cru-
cial. However, it is also possible that the cellular e¡ects caused
by glucose and 2-deoxyglucose might involve di¡erent mech-
anisms or might require di¡erent metabolic situations of the
cells.
The present data exclude a crucial function of all the chosen
serine positions in the inhibitory e¡ect of 2-deoxyglucose. Liu
and colleagues have de¢ned the serine 1023/25 as a phospho-
rylation site for PKC-K [14]. The present data suggest that this
site might indeed be an inhibitory receptor serine residue as a
somewhat elevated insulin stimulated autophosphorylation is
found. However, this potentially inhibitory phosphorylation
site seems not to be required for the 2-deoxyglucose depend-
ent receptor inhibition. Slightly increased basal and insulin
stimulated receptor phosphorylation was also seen with the
994 mutant. Serine 994 might therefore as well be an inhib-
itory serine phosphorylation site which is however also not
required for the 2-deoxyglucose induced receptor inhibition.
Taken together with the negative results of the 32P labeling
experiments the hypothesis of serine phosphorylation of the
receptor as mediator of hyperglycemia and PKC dependent
receptor inhibition could not be proven. Recent data suggest
rather that PKC dependent serine phosphorylation occurs at
IRS-1 [10]. It is however unclear how this mediates receptor
inhibition.
References
[1] DeFronzo, R.A., Bonadonna, R. and Ferrannini, E. (1992) Dia-
betes Care 15, 318^368.
[2] Warram, J.H., Martin, B.H., Krolewski, A.S., Soeldner, J.S. and
Kahn, C.R. (1990) Ann. Intern. Med. 113, 909^915.
[3] Ha«ring, H.U. (1991) Diabetologia 34, 848^861.
[4] White, M.F. and Kahn, C.R. (1994) J. Biol. Chem. 269, 1^4.
[5] Kahn, C.R. (1994) Diabetes 43, 1066^1084.
[6] Mu«ller, H.K., Kellerer, M., Ermel, B., Mu«hlho«fer, A., Ober-
maier-Kusser, B., Vogt, B. and Ha«ring, H.U. (1991) Diabetes
40, 1440^1448.
[7] Berti, L., Mosthaf, L., Kroder, G., Kellerer, M., Tippmer, S.,
Mushack, J., Se¡er, E., Seedorf, K. and Haring, H.U. (1994)
J. Biol. Chem. 269, 3381^3386.
[8] Mosthaf, L., Berti, L., Kellerer, M., Mushak, J., Se¡er, E., Bos-
senmaier, B., Coghlan, M., Siddle, K., Ullrich, A. and Ha«ring,
H.U. (1995) Eur. J. Biochem. 227, 787^791.
[9] Maegawa, H., Ide, R., Hasegawa, M., Ugi, S., Egawa, K., Iwa-
nishi, M., Kikkawa, R., Shigeta, Y. and Kashiwagi, A. (1995)
J. Biol. Chem. 270, 7724^7730.
[10] Kellerer, M., Mushack, J., Se¡er, E., Mischak, H., Ullrich, S.A.
and Ha«ring, H.U. (1998) Diabetologia 41, 833^838.
[11] Pillay, T.S., Whittaker, J., Lammers, R., Ullrich, A. and Siddle,
K. (1991) FEBS Lett. 288, 206^211.
[12] Bollag, G.E., Roth, R.A., Beaudoin, J., Mochly-Rosen, D. and
Koshland, D.E. (1986) Proc. Natl. Acad. Sci. USA 83, 5822^
5824.
Fig. 2. Statistical analysis of insulin induced receptor autophospho-
rylation and the e¡ect of 2-DG. Insulin stimulated and 2-DG prein-
cubated levels of receptor autophosphorylation were measured by
densitometric analysis of ¢ve independent experiments. The value of
the each stimulated receptor was taken as 100% (white bars). The
black bars show the reduced level of the receptor autophosphoryla-
tion after preincubation with 2-DG (n = 5, þ S.E.M.).
FEBS 21877 19-4-99
V. Strack et al./FEBS Letters 449 (1999) 111^114 113
[13] Liu, F. and Roth, R.A. (1994) Biochem. J. 298, 471^477.
[14] Liu, F. and Roth, R.A. (1994) FEBS Lett. 352, 389^392.
[15] Lewis, R.E., Wu, P.G., MacDonald, R.G. and Czech, M.P.
(1990) J. Biol. Chem. 265, 947^954.
[16] Tavare, J.M., Zhang, B., Ellis, L. and Roth, R.A. (1991) J. Biol.
Chem. 266, 21804^21809.
[17] Al Hasani, H., Eisermann, B., Tennagels, N., Magg, C., Passlack,
W., Koenen, M., Muller-Wieland, D., Meyer, H.E. and Klein,
H.W. (1997) FEBS Lett. 400, 65^70.
[18] Danielsen, A.G., Liu, F., Hosomi, Y., Shii, K. and Roth, R.A.
(1995) J. Biol. Chem. 270, 21600^21605.
[19] Hubbard, S.R., Wei, L., Ellis, L. and Hendrickson, W.A. (1994)
Nature 372, 746^754.
[20] Kunkel, T.A. (1985) Proc. Natl. Acad. Sci. USA 82, 488^492.
[21] Gorman, C.M., Gies, D., McGray, G. and Huang, M. (1989)
Virology 171, 377^385.
[22] Chen, C. and Okayama, H. (1987) Mol. Cell Biol. 7, 2745^
2752.
[23] Strack, V., Stoyanov, B., Bossenmaier, B., Mosthaf, L., Kellerer,
M. and Ha«ring, H.U. (1997) Biochem. Biophys. Res. Commun.
239, 235^239.
FEBS 21877 19-4-99
V. Strack et al./FEBS Letters 449 (1999) 111^114114
